All participants in the tirzepatide treatment arms started the study at a dose of tirzepatide 2.5 mg once weekly and then increased the dose in a step-wise approach at four-week intervals to their final randomized maintenance dose of 5 mg (via a 2.5 mg step), 10 mg (via steps at 2.5 mg, 5 mg and 7.5 mg) or 15 mg (via steps at 2.5 mg, 5 mg, 7.5 mg, 10 mg and 12.5 mg)
The evidence supporting this indirect mechanism is strong
Recent studies have begun to shed light on how semaglutide may influence inflammation, a critical component of the immune response
To mitigate these risks, professional societies recommend discontinuing once-weekly GLP-1RAs at least one week prior to surgery
Maybe its an opportunity to have a discussion about maybe slowing down on the weight loss, maybe holding at a lower dose of the medication to give the body time to adjust, Dr